We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+9.06%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.6B
AUM Growth
+$2.6B
(+22%)
Cap. Flow
+$859M
Cap. Flow
% of AUM
5.88%
Top 10 Holdings %
Top 10 Hldgs %
21.92%
Holding
958
New
131
Increased
364
Reduced
334
Closed
74
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$135M |
| 2 |
Royal Bank of Canada
RY
|
+$120M |
| 3 |
Agilent Technologies
A
|
+$72.5M |
| 4 |
UnitedHealth
UNH
|
+$71.5M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$64.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$90.3M |
| 2 |
Amgen
AMGN
|
+$88.7M |
| 3 |
Allstate
ALL
|
+$52.2M |
| 4 |
Union Pacific
UNP
|
+$47.1M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
+$44.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.42% |
| 2 | Technology | 23.2% |
| 3 | Consumer Discretionary | 9.14% |
| 4 | Financials | 8.63% |
| 5 | Communication Services | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
BHP
BHP
$212B
| $5K | ﹤0.01% |
+84
| New | +$5.55K |
|
827
Medtronic
MDT
$108B
| $5K | ﹤0.01% |
37
-1
| -3% | -$126 |
|
828
GSK
GSK
$104B
| $4K | ﹤0.01% |
74
-4
| -5% | -$192 |
|
829
Trane Technologies
TT
$106B
| $4K | ﹤0.01% |
22
+2
| +10% | +$356 |
|
|
RDS.A
830
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $4K | ﹤0.01% |
91
+67
| +279% | +$2.66K |
|
831
Arrow Electronics
ARW
$10.7B
| $3K | ﹤0.01% |
22
-9
| -29% | -$1.05K |
|
|
TEF
832
DELISTED
Telefonica
TEF
| $3K | ﹤0.01% |
647
+37
| +6% | +$160 |
|
833
Banco Bilbao Vizcaya Argentaria
BBVA
$146B
| $2K | ﹤0.01% |
307
+187
| +156% | +$1.11K |
|
834
Eaton
ETN
$153B
| $2K | ﹤0.01% |
16
-1
| -6% | -$144 |
|
|
GRMN
835
Garmin
GRMN
$46.5B
| $2K | ﹤0.01% |
17
+8
| +89% | +$1.12K |
|
|
NVO
836
Novo Nordisk
NVO
$219B
| $2K | ﹤0.01% |
56
-2
| -3% | -$78 |
|
837
Rio Tinto
RIO
$149B
| $2K | ﹤0.01% |
21
-10,698
| -100% | -$920K |
|
838
TE Connectivity
TEL
$59.5B
| $2K | ﹤0.01% |
18
-14
| -44% | -$1.88K |
|
|
WBK
839
DELISTED
Westpac Banking Corporation
WBK
| $2K | ﹤0.01% |
97
| – | – |
|
840
Accenture
ACN
$94.9B
| $1K | ﹤0.01% |
+4
| New | +$1.15K |
|
841
BP
BP
$110B
| $1K | ﹤0.01% |
47
-63
| -57% | -$1.65K |
|
842
Equinor
EQNR
$92.8B
| $1K | ﹤0.01% |
66
-6
| -8% | -$126 |
|
843
Linde
LIN
$235B
| $1K | ﹤0.01% |
5
+1
| +25% | +$292 |
|
|
MRUS
844
DELISTED
Merus
MRUS
| $1K | ﹤0.01% |
+44
| New | +$973 |
|
845
NovoCure
NVCR
$2.04B
| $1K | ﹤0.01% |
3
+1
| +50% | +$195 |
|
846
Pentair
PNR
$10.3B
| $1K | ﹤0.01% |
+17
| New | +$1.12K |
|
847
SAP
SAP
$201B
| $1K | ﹤0.01% |
+10
| New | +$1.39K |
|
848
Sumitomo Mitsui Financial
SMFG
$166B
| $1K | ﹤0.01% |
137
+131
| +2,183% | +$939 |
|
849
Takeda Pharmaceutical
TAK
$55.8B
| $1K | ﹤0.01% |
+78
| New | +$1.33K |
|
850
TotalEnergies
TTE
$188B
| $1K | ﹤0.01% |
+15
| New | +$702 |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2021 Portfolio in Review
As of Q2 2021, Candriam SCA held 958 positions worth $14.6B, up 22% from $12B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Candriam SCA deployed $859M of net new capital in Q2 2021, opening 131 new positions and adding to 364 existing holdings. Its largest new stake was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $90.3M trimmed.
- Candriam SCA's largest Q2 2021 buy was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.
- Candriam SCA added most to Microsoft in Q2 2021, an estimated $135M increase.
- Candriam SCA's biggest Q2 2021 reduction was Bristol-Myers Squibb, cutting an estimated $90.3M.
- Candriam SCA fully exited Tenable Holdings in Q2 2021, selling an estimated $31.6M.
- Candriam SCA's ten largest holdings make up 22% of its $14.6B portfolio in Q2 2021.
- Candriam SCA opened 131 new positions and closed 74 in Q2 2021.
- Candriam SCA's portfolio value rose 22% quarter-over-quarter to $14.6B.
Based on Candriam SCA's 13F filing for Q2 2021, filed 20 Jul 2021.